Anthropic launches AI-driven lab to develop treatments for rare diseases

Anthropic has established a physical lab in the San Francisco Bay Area to automate experiments and develop treatments for rare diseases that pharma typically ignores. The move extends Anthropic's focus from AI models to applied biotech, though details on funding, partnerships, and timelines remain unclear. This signals growing convergence of AI and drug discovery, potentially reshaping R&D economics for neglected diseases.